Clinical Trial Update: Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating apatinib in combination with SBRT for oligometastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Yan Li | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN